The near-12% distribution is entirely funded by realized gains, not return of capital, distinguishing HQH from most ...

Sector - Health fund seekers should consider taking a look at Fidelity Advisor Biotechnology A (FBTAX). FBTAX holds a Zacks ...

BioMarin Pharmaceutical has ended development of BMN 401 in all indications months after reporting mixed phase 3 data on the ...

Note: the trade details cited in this article come from The Claude Portfolio account on X, a third-party account not ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

The biotech will now focus on the two other BiTEs in its pipeline, CTIM-76 and CT-202.

Revolution Medicines is evolving from a clinical-stage biotech to a near-term commercial oncology player. Find out why RVMD ...

As demand grows for advice that is both instant and credible, such platforms rooted in cosmetic science – and validated by ...

Anthropic on August 7, 2026 released an update to the biology safeguards on Claude Fable 5 that the company says cut ...

The study established proof of concept, but lettuce with meat protein is still some distance from ending up in your burger.

All three major stock indexes rose, with the S&P and Nasdaq capping their best week since April.

No new shares issued during the second quarter — common shares outstanding of 20,234,993 at June 30, 2026, unchanged from March 31, 2026; shares outstanding increased from 5,160,383 at December 31, ...